GlassScriptPhysician profile
Ollya Fromal
NPI 1396236220
$14,330.53
in general payments reported to CMS, 2019-2025
16 companies · $10K in 2025
The $10K reported for 2025 was more than what 91% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $392 · 2022: $2,864 · 2023: $527 · 2024: $351 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,870 · Food and Beverage: $3,709 · Travel and Lodging: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,870.00 |
| Food and Beverage | $3,708.72 |
| Travel and Lodging | $496.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $8,815.52 | 2022-2025 | Vabysmo, Susvimo |
| Alcon Vision LLC | $2,496.58 | 2021-2023 | Constellation |
| Abbvie INC. | $551.55 | 2024-2025 | |
| Sight Sciences, INC. | $341.54 | 2021-2023 | Omni Surgical System |
| Apellis Pharmaceuticals, INC. | $289.13 | 2025 | Syfovre |
| Dutch Ophthalmic, USA | $284.54 | 2022-2024 | Eva, Combined Machine, Tissueblue |
| Regeneron Healthcare Solutions, INC. | $269.50 | 2022-2025 | Eylea Hd |
| Astellas Pharma US INC | $219.65 | 2024-2025 | Izervay |
| Harrow Eye, LLC | $206.71 | 2025 | Iheezo, Triesence |
| Bausch & Lomb Americas INC. | $186.05 | 2025 | Stellaris, Xipere, Stellaris |
| Alimera Sciences, INC. | $131.22 | 2024 | Yutiq, Iluvien |
| Ani Pharmaceuticals, INC. | $125.00 | 2025 | Purified Cortrophin Gel |
| Johnson & Johnson Surgical Vision, INC. | $118.29 | 2022 | |
| Alexion Pharmaceuticals, INC. | $114.23 | 2022 | |
| Oculus Surgical INC. | $104.20 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $76.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ollya Fromal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.